These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 8911324)

  • 1. Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?
    Massad MG; McCarthy PM; Smedira NG; Cook DJ; Ratliff NB; Goormastic M; Vargo RL; Navia J; Young JB; Stewart RW
    J Thorac Cardiovasc Surg; 1996 Nov; 112(5):1275-81; discussion 1282-3. PubMed ID: 8911324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
    Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
    Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in continuous-flow left ventricular assist device therapy as a bridge to transplantation: a risk-adjusted comparison using a propensity score-matching analysis.
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; García Sáez D; Amrani M; Bahrami T; De Robertis F; Wahlers T; Banner NR; Popov AF; Simon AR
    Artif Organs; 2015 Mar; 39(3):212-9. PubMed ID: 25175547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices.
    Russo MJ; Hong KN; Davies RR; Chen JM; Sorabella RA; Ascheim DD; Williams MR; Gelijns AC; Stewart AS; Argenziano M; Naka Y
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1425-32.e1-3. PubMed ID: 19931672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology.
    McCarthy PM; Smedira NO; Vargo RL; Goormastic M; Hobbs RE; Starling RC; Young JB
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):904-12. PubMed ID: 9576228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
    Urban M; Pirk J; Dorazilova Z; Netuka I
    Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
    Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.
    Arnaoutakis GJ; George TJ; Kilic A; Weiss ES; Russell SD; Conte JV; Shah AS
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1236-45, 1245.e1. PubMed ID: 21839482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation?
    Shuhaiber J; Hur K; Gibbons R
    J Card Surg; 2009; 24(3):250-5. PubMed ID: 19438776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA sensitization in ventricular assist device recipients: does type of device make a difference?
    Kumpati GS; Cook DJ; Blackstone EH; Rajeswaran J; Abdo AS; Young JB; Starling RC; Smedira NG; McCarthy PM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1800-7. PubMed ID: 15173739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.
    McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
    Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
    Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.